Switzerland · Research startup

CDR-Life Inc.

CDR-Life Inc. is a Swiss biotherapeutics company founded in 2017 and based in Schlieren, Zurich.

Funding reportedLast round: Series A

ResearchHorgen, Switzerland

About CDR-Life Inc.

CDR-Life Inc. is a Swiss biotherapeutics company founded in 2017 and based in Schlieren, Zurich.

The company focuses on developing next-generation immunotherapies for cancer and autoimmune diseases. Led by CEO Christian Leisner and co-founders Dominik Escher and Konstantin von Schulthess, CDR-Life aims to create therapies that precisely target tumor cells while minimizing effects on healthy tissue. The company's core technology, the M-gager® platform, enables the development of highly selective T-cell engagers that target intracellular tumor antigens. This innovative approach allows for the creation of first-in-class immunotherapies for both solid tumors, such as lung and breast cancer, and liquid tumors like multiple myeloma. CDR-Life is currently advancing several investigational drug candidates, with two already in human testing. The company has also established strategic collaborations, including a partnership with Boehringer Ingelheim for an antibody fragment therapy targeting macular degeneration.

What company datasets say CDR-Life Inc. raised

Funding, as reported

Reported in all76Min the source's currency
Rounds1
Last roundSeries A
Last round size76M
Last round dateApr 2022
Investors listed3

Founders and team

From CDR-Life Inc.'s own website: 5 founders, 7 on the team.

Christian LeisnerChief Executive Officer & Co-founder
Konstantin von SchulthessChief Financial Officer & Co-founder
Leonardo BorrasChief Scientific Officer & Co-founder
Rouven Bingel-ErlenmeyerChief Technology Officer & Co-founder
Dr. Dominik EscherChairman & Co-founder
  • Dimitrios ChondrosChief Medical Officer
  • Sarah HollandChief Business Officer
  • Betty ChenResearch Operation Manager
  • Dr. Claudio NessiDirector
  • Dr. Mehdi AinoucheDirector
  • Dr. Nicole OnettoDirector
  • Fanny CavaliéDirector

On a portfolio page

Investors who name them

Each firm lists CDR-Life Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Known for

health careantibody humanizationbiotechnology researchbispecific tcesantigen-specific t cell activationmhc targetingmedical researchimmune system activationbispecific antibodiesautoimmune cell targetingindication-specific therapieshospital & health careantibody stabilitytarget-specific therapyautoimmune treatmentcancer immunotherapy

Built with from their website

Yoast SEOGoogle MapsContact Form 7Google Tag ManagerWordPress.orgPWAFont AwesomeApacheViewport MetaYoast

+8 more

Google AnalyticsCloudflare Rocket LoaderGoogle Analytics 4WordpressMicrosoft Exchange OnlinejQuery MigrateGoogle Maps PlatformPriority Hints

Sector
Research
Industry code
NAICS 541714, 325414, SIC 2834, 2836
Region
Zurich
Full record
Every detail in the company directory

Research in Switzerland

Startups like it

Is this your company?

Add your raise, your deck and your story, and put CDR-Life Inc. in front of investors. Or tell us what we have wrong.